S. Lindsey

发表

HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells.

H. J. Harwood, S. Petras, S. Lindsey, 1999, Journal of lipid research.

Will dietary omega-3 fatty acids change the composition of human milk?

W. Harris, W. Connor, S. Lindsey, 1984, The American journal of clinical nutrition.

Fatty Acid Modulation of Lipoprotein Metabolism by Natural Triglycerides in Hamsters: Lipoprotein Turnover and Hepatic mRNA Abundance

K. Hayes, A. Prończuk, S. Lindsey, 1998 .

Retinal pigment epithelium possesses both LDL and scavenger receptor activity.

K. Hayes, S. Lindsey, Z. F. Stephan, 1989, Investigative ophthalmology & visual science.

LDL enhances monocyte adhesion to endothelial cells in vitro.

K. Hayes, M. Alderson, R. Hoover, 1986, The American journal of pathology.

Tocopherol and Tocotrienol Plasma Transport and Tissue Concentrations: Implications for Their Relative Biological Functions

K. Hayes, A. Prończuk, S. Lindsey, 1992 .

Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells.

K. Hayes, A. Prończuk, S. Lindsey, 1992, Journal of lipid research.

CP-225,917 and CP-263,114, novel Ras farnesylation inhibitors from an unidentified fungus. I. Taxonomy, fermentation, isolation, and biochemical properties.

T. Kaneko, L. Huang, S. Lindsey, 1997, The Journal of antibiotics.

Monocyte adherence to endothelial cells in vitro is increased by beta-VLDL.

K. Hayes, G. Friedman, S. Lindsey, 1987, The American journal of pathology.

Adrenocortical response to adrenocorticotropin in heterozygous familial hypercholesterolemia.

D. Illingworth, S. Lindsey, N. Alam, 1984, The Journal of clinical endocrinology and metabolism.

3-(4-chlorophenyl)-2-(4-diethylaminoethoxyphenyl)-A-pentenonitrile monohydrogen citrate and related analogs. Reversible, competitive, first half-reaction squalene synthetase inhibitors.

H. J. Harwood, S. Petras, S. Lindsey, 1997, Biochemical pharmacology.

Regulation of low-density lipoprotein receptors in the human hepatoma cell line Hep G2.

S. Lindsey, F. Hagemenas, D. D. Illingworth, 1984, Experimental cell research.

Dietary Palmitic Acid (16:O) Enhances High Density Lipoprotein Cholesterol

K. Hayes, A. Prończuk, S. Lindsey, 2008 .

Taurine enhances low density lipoprotein binding. Internalization and degradation by cultured Hep G2 cells.

K. Hayes, S. Lindsey, Z. F. Stephan, 1987, The Journal of biological chemistry.

Dietary saturated fatty acids (12:0, 14:0, 16:0) differ in their impact on plasma cholesterol and lipoproteins in nonhuman primates.

K. Hayes, A. Prończuk, S. Lindsey, 1991, The American journal of clinical nutrition.

Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice

H. Showell, S. Lindsey, P. Bourassa, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice.

B. Rollins, P. Milos, E. Natoli, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Deficient Mice Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein

B. Rollins, P. Milos, E. Natoli, 1999 .

Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages

O. Francone, L. Royer, T. Coskran, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Lactose protects against estrogen-induced pigment gallstones in hamsters fed nutritionally adequate purified diets.

K. Hayes, C. Verdon, A. Prończuk, 1989, The Journal of nutrition.

Dietary Fatty Acids and Blood Cholesterol

K. Hayes, A. Prończuk, S. Lindsey, 1991 .

Dietary Palmitic Acid (16:0) Enhances High Density Lipoprotein Cholesterol and Low Density Lipoprotein Receptor mRNA Abundance in Hamsters

K. Hayes, A. Prończuk, S. Lindsey, 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Inhibition of Mammalian Squalene Synthetase Activity by Zaragozic Acid A Is a Result of Competitive Inhibition Followed by Mechanism-based Irreversible Inactivation

H. J. Harwood, S. Lindsey, 1995, The Journal of Biological Chemistry.

2.P.40 Discovery of the squalene synthetase inhibitor CP-340,868

C. Aldinger, H. J. Harwood, S. Petras, 1997 .